# Integer Holdings Corp: financial statements, quarterly

ITGR · NYSE · CIK 1114483 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/itgr.md) · [Financials](/companies/itgr/financials.md) · [Filings](/companies/itgr/filings.md) · [Insiders](/companies/itgr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/itgr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [397](/filings/0001114483-24-000127.md) | [405 d](/filings/0001114483-26-000003.md) | [408](/filings/0001114483-25-000084.md) | [428](/filings/0001114483-25-000131.md) | [431](/filings/0001114483-25-000134.md) | [449 d](/filings/0001114483-26-000003.md) | [437](/filings/0001114483-26-000015.md) | [476](/filings/0001114483-26-000027.md) | [468](/filings/0001114483-25-000134.md) | [472 d](/filings/0001114483-26-000003.md) | [440](/filings/0001114483-26-000015.md) | [464](/filings/0001114483-26-000027.md) |
| Cost of revenue | $m | [292](/filings/0001114483-24-000127.md) | [295 d](/filings/0001114483-26-000003.md) | [300](/filings/0001114483-25-000084.md) | [311](/filings/0001114483-25-000131.md) | [315](/filings/0001114483-25-000134.md) | [333 d](/filings/0001114483-26-000003.md) | [317](/filings/0001114483-26-000015.md) | [347](/filings/0001114483-26-000027.md) | [342](/filings/0001114483-25-000134.md) | [347 d](/filings/0001114483-26-000003.md) | [330](/filings/0001114483-26-000015.md) | [351](/filings/0001114483-26-000027.md) |
| Gross profit | $m | [105](/filings/0001114483-24-000127.md) | [110 d](/filings/0001114483-26-000003.md) | [108](/filings/0001114483-25-000084.md) | [117](/filings/0001114483-25-000131.md) | [117](/filings/0001114483-25-000134.md) | [117 d](/filings/0001114483-26-000003.md) | [120](/filings/0001114483-26-000015.md) | [129](/filings/0001114483-26-000027.md) | [126](/filings/0001114483-25-000134.md) | [125 d](/filings/0001114483-26-000003.md) | [110](/filings/0001114483-26-000015.md) | [113](/filings/0001114483-26-000027.md) |
| Selling, general and administrative | $m | [41.4](/filings/0001114483-24-000127.md) | [45.3 d](/filings/0001114483-26-000003.md) | [46.4](/filings/0001114483-25-000084.md) | [46.5](/filings/0001114483-25-000131.md) | [44.8](/filings/0001114483-25-000134.md) | [47.5 d](/filings/0001114483-26-000003.md) | [51.2](/filings/0001114483-26-000015.md) | [52.9](/filings/0001114483-26-000027.md) | [50.5](/filings/0001114483-25-000134.md) | [57.2 d](/filings/0001114483-26-000003.md) | [58.7](/filings/0001114483-26-000015.md) | [57.7](/filings/0001114483-26-000027.md) |
| Operating income | $m | [48.8](/filings/0001114483-24-000127.md) | [43.5 d](/filings/0001114483-26-000003.md) | [38.7](/filings/0001114483-25-000084.md) | [54.5](/filings/0001114483-25-000131.md) | [58.0](/filings/0001114483-25-000134.md) | [57.0 d](/filings/0001114483-26-000003.md) | [49.6](/filings/0001114483-26-000015.md) | [59.3](/filings/0001114483-26-000027.md) | [56.4](/filings/0001114483-25-000134.md) | [55.9 d](/filings/0001114483-26-000003.md) | [31.9](/filings/0001114483-26-000015.md) | [34.5](/filings/0001114483-26-000027.md) |
| Interest expense | $m | [12.0](/filings/0001114483-23-000031.md) | [12.7 d](/filings/0001114483-24-000034.md) | [14.7](/filings/0001114483-24-000059.md) | [14.6](/filings/0001114483-25-000131.md) | [14.6](/filings/0001114483-25-000134.md) | [13.2 d](/filings/0001114483-26-000003.md) | [14.8](/filings/0001114483-26-000015.md) | [9.8](/filings/0001114483-26-000027.md) | [9.4](/filings/0001114483-25-000134.md) | [9.3 d](/filings/0001114483-26-000003.md) | [9.7](/filings/0001114483-26-000015.md) | [10.1](/filings/0001114483-26-000027.md) |
| Income tax | $m | [5.1](/filings/0001114483-24-000127.md) | [3.2 d](/filings/0001114483-26-000003.md) | [4.2](/filings/0001114483-25-000084.md) | [8.8](/filings/0001114483-25-000131.md) | [7.1](/filings/0001114483-25-000134.md) | [6.3 d](/filings/0001114483-26-000003.md) | [9.5](/filings/0001114483-26-000015.md) | [8.6](/filings/0001114483-26-000027.md) | [6.3](/filings/0001114483-25-000134.md) | [(1.8) d](/filings/0001114483-26-000003.md) | [3.8](/filings/0001114483-26-000015.md) | [(0.3)](/filings/0001114483-26-000027.md) |
| Net income | $m | [27.3](/filings/0001114483-24-000127.md) | [26.4 d](/filings/0001114483-26-000003.md) | [20.5](/filings/0001114483-25-000084.md) | [31.2](/filings/0001114483-25-000131.md) | [35.4](/filings/0001114483-25-000134.md) | [32.7 d](/filings/0001114483-26-000003.md) | [(22.5)](/filings/0001114483-26-000015.md) | [37.0](/filings/0001114483-26-000027.md) | [39.7](/filings/0001114483-25-000134.md) | [48.6 d](/filings/0001114483-26-000003.md) | [16.5](/filings/0001114483-26-000015.md) | [23.6](/filings/0001114483-26-000027.md) |
| Diluted EPS | $ per share | [0.81](/filings/0001114483-24-000127.md) | not reported | [0.59](/filings/0001114483-25-000084.md) | [0.88](/filings/0001114483-25-000131.md) | [0.99](/filings/0001114483-25-000134.md) | not reported | [(0.66)](/filings/0001114483-26-000015.md) | [1.04](/filings/0001114483-26-000027.md) | [1.11](/filings/0001114483-25-000134.md) | not reported | [0.48](/filings/0001114483-26-000015.md) | [0.69](/filings/0001114483-26-000027.md) |
| Basic EPS | $ per share | [0.82](/filings/0001114483-24-000127.md) | not reported | [0.61](/filings/0001114483-25-000084.md) | [0.93](/filings/0001114483-25-000131.md) | [1.05](/filings/0001114483-25-000134.md) | not reported | [(0.66)](/filings/0001114483-26-000015.md) | [1.06](/filings/0001114483-26-000027.md) | [1.13](/filings/0001114483-25-000134.md) | not reported | [0.48](/filings/0001114483-26-000015.md) | [0.69](/filings/0001114483-26-000027.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.1](/filings/0001114483-23-000031.md) | [23.7](/filings/0001114483-25-000034.md) | [42.2](/filings/0001114483-24-000059.md) | [34.1](/filings/0001114483-24-000114.md) | [35.6](/filings/0001114483-24-000127.md) | [46.5](/filings/0001114483-26-000003.md) | [31.7](/filings/0001114483-25-000084.md) | [23.1](/filings/0001114483-25-000131.md) | [58.9](/filings/0001114483-25-000134.md) | [17.2](/filings/0001114483-26-000027.md) | [8.1](/filings/0001114483-26-000015.md) | [21.4](/filings/0001114483-26-000027.md) |
| Current assets | $m | [609](/filings/0001114483-23-000031.md) | [618](/filings/0001114483-25-000034.md) | [669](/filings/0001114483-24-000059.md) | [677](/filings/0001114483-24-000114.md) | [730](/filings/0001114483-24-000127.md) | [671](/filings/0001114483-26-000003.md) | [702](/filings/0001114483-25-000084.md) | [737](/filings/0001114483-25-000131.md) | [778](/filings/0001114483-25-000134.md) | [770](/filings/0001114483-26-000027.md) | [775](/filings/0001114483-26-000015.md) | [811](/filings/0001114483-26-000027.md) |
| Total assets | $m | [2,839](/filings/0001114483-23-000031.md) | [2,943](/filings/0001114483-25-000034.md) | [3,116](/filings/0001114483-24-000059.md) | [3,126](/filings/0001114483-24-000114.md) | [3,168](/filings/0001114483-24-000127.md) | [3,078](/filings/0001114483-26-000003.md) | [3,298](/filings/0001114483-25-000084.md) | [3,371](/filings/0001114483-25-000131.md) | [3,397](/filings/0001114483-25-000134.md) | [3,411](/filings/0001114483-26-000027.md) | [3,412](/filings/0001114483-26-000015.md) | [3,424](/filings/0001114483-26-000027.md) |
| Current liabilities | $m | [203](/filings/0001114483-23-000031.md) | [221](/filings/0001114483-25-000034.md) | [201](/filings/0001114483-24-000059.md) | [206](/filings/0001114483-24-000114.md) | [222](/filings/0001114483-24-000127.md) | [227](/filings/0001114483-26-000003.md) | [206](/filings/0001114483-25-000084.md) | [216](/filings/0001114483-25-000131.md) | [210](/filings/0001114483-25-000134.md) | [232](/filings/0001114483-26-000027.md) | [206](/filings/0001114483-26-000015.md) | [217](/filings/0001114483-26-000027.md) |
| Total liabilities | $m | [1,376](/filings/0001114483-23-000031.md) | [1,424](/filings/0001114483-25-000034.md) | [1,591](/filings/0001114483-24-000059.md) | [1,573](/filings/0001114483-24-000114.md) | [1,546](/filings/0001114483-24-000127.md) | [1,459](/filings/0001114483-26-000003.md) | [1,691](/filings/0001114483-25-000084.md) | [1,667](/filings/0001114483-25-000131.md) | [1,651](/filings/0001114483-25-000134.md) | [1,664](/filings/0001114483-26-000027.md) | [1,715](/filings/0001114483-26-000015.md) | [1,705](/filings/0001114483-26-000027.md) |
| Long-term debt | $m | [941](/filings/0001114483-23-000031.md) | [960](/filings/0001114483-25-000034.md) | [1,141](/filings/0001114483-24-000059.md) | [1,119](/filings/0001114483-24-000114.md) | [1,074](/filings/0001114483-24-000127.md) | [980](/filings/0001114483-26-000003.md) | [1,235](/filings/0001114483-25-000084.md) | [1,202](/filings/0001114483-25-000131.md) | [1,194](/filings/0001114483-25-000134.md) | [1,185](/filings/0001114483-26-000027.md) | [1,252](/filings/0001114483-26-000015.md) | [1,238](/filings/0001114483-26-000027.md) |
| Current portion of debt | $m | [0.0](/filings/0001114483-23-000031.md) | [0.0](/filings/0001114483-25-000034.md) | [0.0](/filings/0001114483-24-000059.md) | [0.0](/filings/0001114483-24-000114.md) | [5.0](/filings/0001114483-24-000127.md) | [10.0](/filings/0001114483-26-000003.md) | [0.0](/filings/0001114483-25-000084.md) | [0.0](/filings/0001114483-25-000131.md) | [0.0](/filings/0001114483-25-000134.md) | [0.0](/filings/0001114483-26-000027.md) | [0.0](/filings/0001114483-26-000015.md) | [0.0](/filings/0001114483-26-000027.md) |
| Shareholders' equity | $m | [1,463](/filings/0001114483-24-000127.md) | [1,519](/filings/0001114483-26-000003.md) | [1,525](/filings/0001114483-25-000131.md) | [1,554](/filings/0001114483-25-000134.md) | [1,621](/filings/0001114483-25-000134.md) | [1,619](/filings/0001114483-26-000027.md) | [1,607](/filings/0001114483-26-000027.md) | [1,704](/filings/0001114483-26-000027.md) | [1,746](/filings/0001114483-25-000134.md) | [1,747](/filings/0001114483-26-000027.md) | [1,697](/filings/0001114483-26-000027.md) | [1,719](/filings/0001114483-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [62.3 d](/filings/0001114483-24-000127.md) | [55.6 d](/filings/0001114483-26-000003.md) | [23.2](/filings/0001114483-25-000084.md) | [47.2 d](/filings/0001114483-25-000131.md) | [71.5 d](/filings/0001114483-25-000134.md) | [63.2 d](/filings/0001114483-26-000003.md) | [31.3](/filings/0001114483-26-000015.md) | [43.9 d](/filings/0001114483-26-000027.md) | [65.6 d](/filings/0001114483-25-000134.md) | [55.4 d](/filings/0001114483-26-000003.md) | [24.7](/filings/0001114483-26-000015.md) | [59.7 d](/filings/0001114483-26-000027.md) |
| Capital expenditure | $m | [25.5 d](/filings/0001114483-24-000127.md) | [37.1 d](/filings/0001114483-26-000003.md) | [29.1](/filings/0001114483-25-000084.md) | [31.2 d](/filings/0001114483-25-000131.md) | [26.0 d](/filings/0001114483-25-000134.md) | [19.1 d](/filings/0001114483-26-000003.md) | [25.2](/filings/0001114483-26-000015.md) | [19.0 d](/filings/0001114483-26-000027.md) | [19.3 d](/filings/0001114483-25-000134.md) | [27.5 d](/filings/0001114483-26-000003.md) | [24.0](/filings/0001114483-26-000015.md) | [22.7 d](/filings/0001114483-26-000027.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001114483-26-000015.md) | [0.0 d](/filings/0001114483-26-000027.md) | not reported | not reported | [50.0](/filings/0001114483-26-000015.md) | [0.0 d](/filings/0001114483-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.3](/filings/0001114483-23-000031.md) | [33.6](/filings/0001114483-24-000059.md) | [33.7](/filings/0001114483-24-000114.md) | [33.8](/filings/0001114483-24-000127.md) | [35.0](/filings/0001114483-25-000084.md) | [35.5](/filings/0001114483-25-000131.md) | [35.8](/filings/0001114483-25-000134.md) | [33.9](/filings/0001114483-26-000015.md) | [35.7](/filings/0001114483-26-000027.md) | [35.6](/filings/0001114483-25-000134.md) | [34.4](/filings/0001114483-26-000015.md) | [34.1](/filings/0001114483-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,992,048 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001114483-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.